Clinical trial
Early Two-dose Measles Vaccination Trial
NCT00168558 · Bandim Health Project, Other · Completed
Key facts
| NCT number | NCT00168558 |
|---|---|
| Title | Early Two-dose Measles Vaccination Trial |
| Official title | Measles Vaccination in Guinea-Bissau. Strategies to Reduce Disease Burden and Improve Child Survival |
| Lead sponsor | Bandim Health Project, Other |
| Collaborators | Danish Council for Development Research Novo Nordisk A/S Industry AP Moeller Foundation Medical Research Council Unit, The Gambia |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Measles |
| Intervention type | Biological |
| Interventions | Measles vaccine |
| Enrollment | 5,879 |
| Start date | Jul 1, 2003 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 6, 2012 |
| Countries | Guinea-Bissau |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: